AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9483407 — intervention group
Group type: EXPERIMENTAL
Intervention: Hystochrom
Number of subjects: 0
Study 8452169 — intervention group
Group type: EXPERIMENTAL
Intervention: Fleroxacin 400 mg once a day for 7 days
Number of subjects: 194
Study 8452169 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin 500 mg three times daily for 7 days
Number of subjects: 194
Study 2869060 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam treatment
Number of subjects: 60
Study 2869060 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 31705874 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib
Number of subjects: 92
Study 31705874 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 92
Study 30240874 — intervention group
Group type: EXPERIMENTAL
Intervention: High coach support condition
Number of subjects: 356
Study 30240874 — intervention group
Group type: COMPARATOR
Intervention: Low coach support condition
Number of subjects: 356
Study 30240874 — intervention group
Group type: EXPERIMENTAL
Intervention: Both conditions (Low and High coach support)
Number of subjects: 356
Study 26620042 — intervention group
Group type: EXPERIMENTAL
Intervention: Bi‐NCPAP
Number of subjects: 132
Study 26620042 — intervention group
Group type: COMPARATOR
Intervention: Re‐NCPAP
Number of subjects: 132
Study 24446523 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolutegravir (DTG) 50 mg BID
Number of subjects: 0
Study 22260745 — intervention group
Group type: EXPERIMENTAL
Intervention: 26% NaCl and heparin
Number of subjects: 0
Study 22260745 — intervention group
Group type: COMPARATOR
Intervention: Standard heparin
Number of subjects: 0
Study 20339636 — intervention group
Group type: EXPERIMENTAL
Intervention: VrHB‐IB (Instituto Butantan)
Number of subjects: 419
Study 20339636 — intervention group
Group type: COMPARATOR
Intervention: Engerix B(R) (Glaxo Smith Kline)
Number of subjects: 419
Study 18698521 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital noise reduction (DNR) on with 4-second onset time
Number of subjects: 25
Study 18698521 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital noise reduction (DNR) on with 8-second onset time
Number of subjects: 25
Study 18698521 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital noise reduction (DNR) on with 16-second onset time
Number of subjects: 25
Study 18698521 — intervention group
Group type: COMPARATOR
Intervention: Digital noise reduction (DNR) off
Number of subjects: 25
Study 18698521 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital noise reduction (DNR) on or off
Number of subjects: 25
Study 15952999 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 1603
Study 15952999 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone
Number of subjects: 1603
Study 14598948 — intervention group
Group type: EXPERIMENTAL
Intervention: Profiling dialysate sodium and ultrafiltration rate
Number of subjects: 0
Study 14598948 — intervention group
Group type: COMPARATOR
Intervention: Standard haemodialysis without profiling
Number of subjects: 0
Study 11076326 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroxine (T4) supplementation (10 or 20 micrograms/kg; intravenous or nasogastric tube) for 21 days
Number of subjects: 49
Study 11076326 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 8731625 — intervention group
Group type: EXPERIMENTAL
Intervention: ORT with immediate modified feeding
Number of subjects: 59
Study 8731625 — intervention group
Group type: COMPARATOR
Intervention: ORT alone
Number of subjects: 59
Study 1574972 — intervention group
Group type: EXPERIMENTAL
Intervention: Crystalloid volume loading (10 ml.kg‐1 b.w.)
Number of subjects: 90
Study 1574972 — intervention group
Group type: COMPARATOR
Intervention: Control group (no fluid loading)
Number of subjects: 90
Study 2859650 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin-28 (SS-28) infusion
Number of subjects: 0
Study 2859650 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin-14 (SS-14) infusion at 75 pmol/kg-h
Number of subjects: 0
Study 2859650 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin-14 (SS-14) infusion at 500 pmol/kg-h
Number of subjects: 0
Study 2859650 — intervention group
Group type: COMPARATOR
Intervention: Somatostatin-28 (SS-28) compared to Somatostatin-14 (SS-14)
Number of subjects: 0
Study 30968810 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-element psychosocial intervention
Number of subjects: 260
Study 30968810 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 260
Study 29557669 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemonitoring
Number of subjects: 312
Study 29557669 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 312
Study 26360708 — intervention group
Group type: EXPERIMENTAL
Intervention: Learn to BE SAFE with Emmy program (n=131)
Number of subjects: 245
Study 26360708 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (n=114)
Number of subjects: 245
Study 25467395 — intervention group
Group type: EXPERIMENTAL
Intervention: Overground training session
Number of subjects: 56
Study 25467395 — intervention group
Group type: COMPARATOR
Intervention: Treadmill training session
Number of subjects: 56
Study 23057028 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric mallet
Number of subjects: 80
Study 23057028 — intervention group
Group type: COMPARATOR
Intervention: Hand mallet
Number of subjects: 80
Study 19911168 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg dose of R317573
Number of subjects: 12
Study 19911168 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg dose of R317573
Number of subjects: 12
Study 19911168 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 17873677 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg immediate-release methylphenidate (IR)
Number of subjects: 0
Study 17873677 — intervention group
Group type: EXPERIMENTAL
Intervention: 108 mg extended-release methylphenidate (osmotic release oral system [OROS])
Number of subjects: 0
Study 17873677 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15857282 — intervention group
Group type: EXPERIMENTAL
Intervention: N-chlorotaurine (1% aqueous solution)
Number of subjects: 60
Study 15857282 — intervention group
Group type: COMPARATOR
Intervention: Gentamicin (control)
Number of subjects: 60
Study 12221468 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant polychemotherapy (dacarbazine, vincristine, 5‐fluorouracil, hydroxyurea)
Number of subjects: 224
Study 12221468 — intervention group
Group type: EXPERIMENTAL
Intervention: DTIC monotherapy or DTIC plus interferon‐alfa
Number of subjects: 224
Study 12221468 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 224
Study 9881560 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorzolamide
Number of subjects: 105
Study 9881560 — intervention group
Group type: COMPARATOR
Intervention: Acetazolamide
Number of subjects: 105
Study 8003853 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide 320 micrograms
Number of subjects: 9
Study 8003853 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline 500 micrograms
Number of subjects: 9
Study 8003853 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide 160 micrograms
Number of subjects: 9
Study 8003853 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide 160 micrograms and 320 micrograms, Terbutaline 500 micrograms
Number of subjects: 9
Study 2967315 — intervention group
Group type: EXPERIMENTAL
Intervention: Cromolyn sodium
Number of subjects: 0
Study 2967315 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone
Number of subjects: 0
Study 2967315 — intervention group
Group type: EXPERIMENTAL
Intervention: Procaterol
Number of subjects: 0
Study 2967315 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2967315 — intervention group
Group type: COMPARATOR
Intervention: Exercise challenge
Number of subjects: 0
Study 2967315 — intervention group
Group type: COMPARATOR
Intervention: Antigen challenge
Number of subjects: 0
Study 29476530 — intervention group
Group type: EXPERIMENTAL
Intervention: Jaw contractions (20% maximal voluntary contraction)
Number of subjects: 16
Study 29476530 — intervention group
Group type: EXPERIMENTAL
Intervention: O-oris contractions (20% maximal voluntary contraction)
Number of subjects: 16
Study 29476530 — intervention group
Group type: EXPERIMENTAL
Intervention: O-oculi contractions (20% maximal voluntary contraction)
Number of subjects: 16
Study 27393856 — intervention group
Group type: EXPERIMENTAL
Intervention: Admission temperature ≤35.5°C (hypothermia)
Number of subjects: 398
Study 27393856 — intervention group
Group type: COMPARATOR
Intervention: Admission temperature >35.5°C (control)
Number of subjects: 398
Study 24846910 — intervention group
Group type: EXPERIMENTAL
Intervention: High-viscosity glass ionomer cement (GIC group)
Number of subjects: 2776
Study 24846910 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin-based sealant with fluoride (fluoride-RB group)
Number of subjects: 2776
Study 24846910 — intervention group
Group type: COMPARATOR
Intervention: Resin-based sealant without fluoride (RB group)
Number of subjects: 2776
Study 23855708 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex intervention to reduce dietary glycaemic load and saturated fat intake, and increase physical activity
Number of subjects: 183
Study 23855708 — intervention group
Group type: COMPARATOR
Intervention: Routine antenatal care (Control)
Number of subjects: 183
Study 21729315 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient decision aid
Number of subjects: 138
Study 21729315 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 138
Study 19248045 — intervention group
Group type: COMPARATOR
Intervention: VBMCP
Number of subjects: 268
Study 19248045 — intervention group
Group type: EXPERIMENTAL
Intervention: VBMCP + HiCy + IFN
Number of subjects: 268
Study 16978071 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate ingestion
Number of subjects: 12
Study 16978071 — intervention group
Group type: COMPARATOR
Intervention: Placebo ingestion
Number of subjects: 12
Study 16978071 — intervention group
Group type: EXPERIMENTAL
Intervention: Both carbohydrate and placebo ingestion
Number of subjects: 12
Study 15330879 — intervention group
Group type: EXPERIMENTAL
Intervention: Practical Skills intervention (1.5-hour class on practical aspects of breastfeeding)
Number of subjects: 981
Study 15330879 — intervention group
Group type: EXPERIMENTAL
Intervention: Attitudes intervention (two 1-hour classes exploring family and community attitudes toward breastfeeding)
Number of subjects: 981
Study 15330879 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 981
Study 11553140 — intervention group
Group type: EXPERIMENTAL
Intervention: Cool water compresses
Number of subjects: 9
Study 11553140 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiologic saline compresses
Number of subjects: 9
Study 9480458 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol 200 micrograms 3 times a day for 1 month
Number of subjects: 20
Study 8298198 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg alendronate
Number of subjects: 65
Study 8298198 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg alendronate
Number of subjects: 65
Study 8298198 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg alendronate
Number of subjects: 65
Study 8298198 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 6232583 — intervention group
Group type: EXPERIMENTAL
Intervention: Water diuresis alone (group I, n = 19)
Number of subjects: 51
Study 6232583 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 50 mg/day (group II, n = 19)
Number of subjects: 51
Study 6232583 — intervention group
Group type: COMPARATOR
Intervention: Neutral phosphate preparation 1500 mg/day (group III, n = 13)
Number of subjects: 51
Study 31083841 — intervention group
Group type: EXPERIMENTAL
Intervention: Caring for Caregivers program (educational intervention)
Number of subjects: 34
Study 31083841 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 34
Study 28589504 — intervention group
Group type: EXPERIMENTAL
Intervention: Community mobilization and mobile HTC intervention
Number of subjects: 13755
Study 27106833 — intervention group
Group type: EXPERIMENTAL
Intervention: Baduanjin exercise
Number of subjects: 110
Study 27106833 — intervention group
Group type: COMPARATOR
Intervention: Usual exercise
Number of subjects: 110
Study 25215557 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium (1000 mg/d)
Number of subjects: 118
Study 25215557 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D (50000 IU/wk)
Number of subjects: 118
Study 25215557 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint calcium (1000 mg/d) and vitamin D (50000 IU/wk)
Number of subjects: 118
Study 22179810 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose-dependent insulinotropic polypeptide (GIP)
Number of subjects: 0
Study 22179810 — intervention group
Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 0
Study 20974601 — intervention group
Group type: EXPERIMENTAL
Intervention: telcagepant 140 mg
Number of subjects: 1677
Study 20974601 — intervention group
Group type: EXPERIMENTAL
Intervention: telcagepant 280 mg
Number of subjects: 1677
Study 20974601 — intervention group
Group type: EXPERIMENTAL
Intervention: telcagepant 140 mg and 280 mg
Number of subjects: 1677
Study 20974601 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1677
Study 18043101 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended transthoracic esophagectomy with en bloc lymphadenectomy
Number of subjects: 220
Study 18043101 — intervention group
Group type: COMPARATOR
Intervention: Limited transhiatal esophagectomy
Number of subjects: 220
Study 18043101 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended transthoracic esophagectomy
Number of subjects: 220
Study 18022088 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-ppm inhaled NO
Number of subjects: 20
Study 18022088 — intervention group
Group type: COMPARATOR
Intervention: Standard anesthetic gas mixture (control group)
Number of subjects: 20
Study 15447816 — intervention group
Group type: EXPERIMENTAL
Intervention: Early enteral nutrition with synbiotics (including four kinds of lactic acid bacteria and four kinds of fibers)
Number of subjects: 40
Study 15447816 — intervention group
Group type: COMPARATOR
Intervention: Early enteral nutrition with synbiotics (only four kinds of fibers)
Number of subjects: 40
Study 10910854 — intervention group
Group type: COMPARATOR
Intervention: 0.75% ropivacaine alone (group Ropivacaine, n = 15)
Number of subjects: 30
Study 10910854 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine plus 1 microg/kg clonidine (group Ropivacaine‐Clonidine, n = 15)
Number of subjects: 30
Study 8764789 — intervention group
Group type: EXPERIMENTAL
Intervention: Excimer laser phototherapeutic keratectomy (PTK)
Number of subjects: 26
Study 1461853 — intervention group
Group type: EXPERIMENTAL
Intervention: One dose of intravenous Augmentin (amoxycillin 250 mg and clavulanic acid 125 mg)
Number of subjects: 900
Study 1461853 — intervention group
Group type: COMPARATOR
Intervention: Three doses of intravenous Augmentin (amoxycillin 250 mg and clavulanic acid 125 mg) every 8 hours
Number of subjects: 900
Study 1461853 — intervention group
Group type: EXPERIMENTAL
Intervention: One dose of intravenous Augmentin
Number of subjects: 900
Study 1461853 — intervention group
Group type: COMPARATOR
Intervention: Three doses of intravenous Augmentin
Number of subjects: 900
Study 6364370 — intervention group
Group type: EXPERIMENTAL
Intervention: Isomil, a soy isolate formula
Number of subjects: 46
Study 6364370 — intervention group
Group type: COMPARATOR
Intervention: Similac with Iron, a common milk-based formula
Number of subjects: 46
Study 6364370 — intervention group
Group type: COMPARATOR
Intervention: Similac 24 LBW, a hypercaloric milk-based formula
Number of subjects: 46
Study 30057015 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic and selenium co-supplementation (200 μg/day selenium plus 8 × 10^9 CFU/day probiotic)
Number of subjects: 54
Study 27974102 — intervention group
Group type: EXPERIMENTAL
Intervention: CoQ10 (DDM Chinone®) at a dose of 200 mg×2/day
Number of subjects: 22
Study 27974102 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 22
Study 24671488 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional treatment (Tubigrip)
Number of subjects: 126
Study 24671488 — intervention group
Group type: COMPARATOR
Intervention: Plaster of Paris (POP)
Number of subjects: 126
Study 23997992 — intervention group
Group type: EXPERIMENTAL
Intervention: SipSmartER
Number of subjects: 25
Study 23997992 — intervention group
Group type: COMPARATOR
Intervention: MoveMore
Number of subjects: 25
Study 23997992 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 25
Study 21593674 — intervention group
Group type: EXPERIMENTAL
Intervention: Variable stiffness colonoscope
Number of subjects: 110
Study 21593674 — intervention group
Group type: COMPARATOR
Intervention: Standard colonoscope
Number of subjects: 110
Study 19404632 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed combination (200 mg artesunate + 540 mg amodiaquine)
Number of subjects: 24
Study 19404632 — intervention group
Group type: EXPERIMENTAL
Intervention: Loose combination (200 mg artesunate + 612 mg amodiaquine)
Number of subjects: 24
Study 19404632 — intervention group
Group type: EXPERIMENTAL
Intervention: Both combinations
Number of subjects: 24
Study 16188428 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 4 mg (group A)
Number of subjects: 43
Study 16188428 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 10 mg (group B)
Number of subjects: 43
Study 16188428 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 10 mg as sub‐mucosal injection (group C)
Number of subjects: 43
Study 16188428 — intervention group
Group type: COMPARATOR
Intervention: Control (no steroid administration)
Number of subjects: 43
Study 14514570 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual Diabetes Assessment Program (ADAP) assessments at intervention sites (HbA(1c), blood pressure, lipids, smoking, retinal photos, urine microalbumin, and foot examination)
Number of subjects: 284
Study 14514570 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual Diabetes Assessment Program (ADAP) assessments at intervention sites
Number of subjects: 284
Study 14514570 — intervention group
Group type: COMPARATOR
Intervention: Comparison sites with ADAP assessments at year 2
Number of subjects: 284
Study 10937514 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 22
Study 10937514 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 8874840 — intervention group
Group type: EXPERIMENTAL
Intervention: Low birth weight (LBW) children (n = 473)
Number of subjects: 823
Study 8874840 — intervention group
Group type: COMPARATOR
Intervention: Normal birth weight (NBW) children (n = 350)
Number of subjects: 823
Study 1394057 — intervention group
Group type: COMPARATOR
Intervention: Mitomycin C alone
Number of subjects: 133
Study 1394057 — intervention group
Group type: EXPERIMENTAL
Intervention: MVP (mitomycin C, vinblastine, and cisplatin)
Number of subjects: 133
Study 1394057 — intervention group
Group type: EXPERIMENTAL
Intervention: MVP
Number of subjects: 133
Study 3838425 — intervention group
Group type: EXPERIMENTAL
Intervention: Orange juice (13 g of carbohydrate)
Number of subjects: 5
Study 3838425 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole milk (13 g of carbohydrate)
Number of subjects: 5
Study 3838425 — intervention group
Group type: EXPERIMENTAL
Intervention: Skim milk (13 g of carbohydrate)
Number of subjects: 5
Study 28905341 — intervention group
Group type: EXPERIMENTAL
Intervention: iDrive powered stapling system
Number of subjects: 40
Study 28905341 — intervention group
Group type: COMPARATOR
Intervention: EndoGIA conventional stapler
Number of subjects: 40
Study 30001930 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT) plus treatment as usual
Number of subjects: 487
Study 30001930 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 487
Study 30001930 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 487
Study 26491889 — intervention group
Group type: EXPERIMENTAL
Intervention: Ialuril Soft Gels in hypo-moderate group
Number of subjects: 40
Study 26491889 — intervention group
Group type: COMPARATOR
Intervention: RT alone in hypo-moderate group
Number of subjects: 40
Study 26491889 — intervention group
Group type: EXPERIMENTAL
Intervention: Ialuril Soft Gels in hypo-extreme group
Number of subjects: 40
Study 26491889 — intervention group
Group type: COMPARATOR
Intervention: RT alone in hypo-extreme group
Number of subjects: 40
Study 26491889 — intervention group
Group type: EXPERIMENTAL
Intervention: Ialuril Soft Gels
Number of subjects: 40
Study 26491889 — intervention group
Group type: COMPARATOR
Intervention: RT alone
Number of subjects: 40
Study 24946633 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-way quintuple puncture group
Number of subjects: 90
Study 24946633 — intervention group
Group type: COMPARATOR
Intervention: Common quintuple puncture group
Number of subjects: 90
Study 24946633 — intervention group
Group type: COMPARATOR
Intervention: Fire needling group
Number of subjects: 90
Study 22752862 — intervention group
Group type: EXPERIMENTAL
Intervention: Fidaxomicin 200 mg twice per day for 10 days
Number of subjects: 89
Study 22752862 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin 125 mg 4 times per day for 10 days
Number of subjects: 89
Study 20099952 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 115
Study 20099952 — intervention group
Group type: COMPARATOR
Intervention: Wait-list condition (Control)
Number of subjects: 115
Study 18058349 — intervention group
Group type: EXPERIMENTAL
Intervention: Exalt
Number of subjects: 0
Study 18058349 — intervention group
Group type: COMPARATOR
Intervention: MNL (Commit)
Number of subjects: 0
Study 18058349 — intervention group
Group type: EXPERIMENTAL
Intervention: Ariva
Number of subjects: 0
Study 15680854 — intervention group
Group type: EXPERIMENTAL
Intervention: SMA‐CPB (surface modifying active copolymer)
Number of subjects: 68
Study 15680854 — intervention group
Group type: EXPERIMENTAL
Intervention: SMA‐CPB
Number of subjects: 68